JP3118939B2 - Method for producing optically active 2-hydroxy-2-norbornanecarboxylic acid - Google Patents

Method for producing optically active 2-hydroxy-2-norbornanecarboxylic acid

Info

Publication number
JP3118939B2
JP3118939B2 JP04056600A JP5660092A JP3118939B2 JP 3118939 B2 JP3118939 B2 JP 3118939B2 JP 04056600 A JP04056600 A JP 04056600A JP 5660092 A JP5660092 A JP 5660092A JP 3118939 B2 JP3118939 B2 JP 3118939B2
Authority
JP
Japan
Prior art keywords
mmol
acid
hydroxy
nmr
crude
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP04056600A
Other languages
Japanese (ja)
Other versions
JPH05221918A (en
Inventor
尚之 吉田
光代 杉浦
和利 宮沢
靖幸 小泉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JNC Corp
Original Assignee
Chisso Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chisso Corp filed Critical Chisso Corp
Priority to JP04056600A priority Critical patent/JP3118939B2/en
Priority to US07/931,993 priority patent/US5266728A/en
Priority to EP92307629A priority patent/EP0528694B1/en
Priority to SG1996001566A priority patent/SG54127A1/en
Publication of JPH05221918A publication Critical patent/JPH05221918A/en
Application granted granted Critical
Publication of JP3118939B2 publication Critical patent/JP3118939B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は様々な生理活性物質の合
成中間体として有用な光学活性(+)−、及び(−)−
2−ヒドロキシ−2−ノルボルナンカルボン酸の製造方
法に関する。
The present invention relates to optically active (+)-and (-)-useful as synthetic intermediates of various physiologically active substances.
The present invention relates to a method for producing 2-hydroxy-2-norbornanecarboxylic acid .

【0002】[0002]

【従来の技術】近年、生理活性物質を光学活性体として
合成することの重要性が高まってきている。ある物質に
複数の光学異性体が存在する場合、各異性体間でその活
性に差異が認められることが多いが、通常強い活性を示
すのは一異性体であり、それ以外の異性体は活性が弱い
か、しばしば望ましくない毒性を示すことが知られてい
る。従って、生理活性物質を、特に医薬品として合成す
る場合には、望ましい光学異性体を選択的に合成するこ
とが、十分な生理活性を発現させるためのみならず、安
全面からも強く望まれる。
2. Description of the Related Art In recent years, the importance of synthesizing a physiologically active substance as an optically active substance has been increasing. When a substance has multiple optical isomers, the activity is often different between the isomers, but one isomer usually shows strong activity, and the other isomers are active. Are known to be weak or often exhibit undesirable toxicity. Therefore, in the case of synthesizing a physiologically active substance, particularly as a pharmaceutical, it is strongly desired to selectively synthesize a desired optical isomer not only in order to exhibit sufficient physiological activity but also in view of safety.

【0003】本発明に於ける光学活性2−ヒドロキシ−
2−ノルボルナンカルボン酸は、本発明者らによって初
めて合成された新規化合物である。この新規化合物は様
々な生理活性物質の合成中間体として非常に有用な化合
物である。例えば、(+)−2−ヒドロキシ−2−ノル
ボルナンカルボン酸から(+)−2−ノルボルナンに誘
導することにより、血液凝固阻止剤として有用なトロン
ボキサンA受容体アンタゴニスト(Narisada
ら、J.Med.Chem.,31,1847(198
8)、Hamanakaら、Tetrahedron
Lett.,30,2399(1989))を合成する
ことができる。しかしながら、過去に於いてはラセミ体
の合成例(Wiltら、J.Am.Chem.So
c.,90,6135(1968))は報告されている
ものの、光学活性の工業的に優れた効率的な合成法は知
られていなかった。
The optically active 2-hydroxy- according to the present invention
2-norbornanecarboxylic acid is a novel compound synthesized for the first time by the present inventors. This novel compound is a very useful compound as a synthetic intermediate for various physiologically active substances. For example, (+) - 2-hydroxy-2-norbornane carboxylic acid (+) - by inducing a 2-norbornane, useful thromboxane A 2 receptor antagonists as anticoagulant (Narisada
J. et al. Med. Chem. , 31 , 1847 (198
8), Hamanaka et al., Tetrahedron
Lett. , 30 , 2399 (1989) ) can be synthesized. However, in the past, examples of racemic synthesis (Wilt et al., J. Am. Chem. So
c. , 90 , 6135 (1968)), but an industrially efficient and efficient optically active synthetic method was not known.

【0004】[0004]

【発明が解決しようとする課題】本発明は、この光学活
性体を効率よく大量生産するための研究過程において見
出された新規な光学活性2−ヒドロキシ−2−ノルボル
ナンカルボン酸、及びその製造方法を提供するにある。
DISCLOSURE OF THE INVENTION The present invention relates to a novel optically active 2-hydroxy-2-norbornanecarboxylic acid discovered in the course of research for efficiently mass-producing this optically active substance, and a method for producing the same. To provide.

【0005】[0005]

【課題を解決するための手段】本発明は、次の式(I)The present invention provides the following formula (I):

【0006】[0006]

【化5】 Embedded image

【0007】で表される光学活性(+)−2−ヒドロキ
シ−2−ノルボルナンカルボン酸および、次の式(I')
An optically active (+)-2-hydroxy-2-norbornanecarboxylic acid represented by the following formula (I ′):

【0008】[0008]

【化6】 Embedded image

【0009】で表される光学活性(−)−2−ヒドロキ
シ−2−ノルボルナンカルボン酸を特徴とする。次に本
発明の化合物の製法について述べる。本発明の光学活性
(+)−2−ヒドロキシ−2−ノルボルナンカルボン酸
(I)は、以下の反応工程に従って製造することができ
る。
An optically active (-)-2-hydroxy-2-norbornanecarboxylic acid represented by the formula: Next, a method for producing the compound of the present invention will be described. The optically active (+)-2-hydroxy-2-norbornanecarboxylic acid (I) of the present invention can be produced according to the following reaction steps.

【0010】[0010]

【化7】 Embedded image

【0011】[0011]

【化8】 Embedded image

【0012】(R1、R2はアルキル基、アラルキル基、ア
リール基、シクロアルキル基を示す)を示す。またMは
水素、またはリチウム、ナトリウム、カリウム等の金属
原子を示す。〕。本発明の出発物質である(II)で表され
る化合物は、(S)−乳酸エステル、(S)−(+)−
パントイルラクトン、または(S)−(−)−N−メチ
ル−2−ヒドロキシコハク酸イミド等をアクリル酸クロ
リドと反応させることにより、光学純度よく取得するこ
とが出来る(Pollら、Tetrahedron Lett.,25, 2191(198
4); 30, 5595(1989)) 。
(R 1 and R 2 each represent an alkyl group, an aralkyl group, an aryl group, or a cycloalkyl group). M represents hydrogen or a metal atom such as lithium, sodium, and potassium. ]. The compound represented by (II), which is a starting material of the present invention, includes (S) -lactic acid ester and (S)-(+)-
By reacting pantoyl lactone or (S)-(-)-N-methyl-2-hydroxysuccinimide with acrylic acid chloride, it can be obtained with high optical purity (Poll et al., Tetrahedron Lett., 25 , 2191 (198
4); 30 , 5595 (1989)).

【0013】式(III)で表される化合物は、式(II)で表
される化合物をルイス酸触媒の存在下、シクロペンタジ
エンとディールス・アルダー反応させることにより、合
成できる。反応に用いられる触媒の例としては、四塩化
チタン等が挙げられる。反応溶媒としては、塩化メチレ
ン、クロロホルム、ジクロロエタン等のハロゲン系溶
媒、またはこれらとペンタン、ヘキサン、ヘプタン、石
油エーテル等の炭化水素系溶液との混合溶媒を用いるこ
とが出来る。反応温度は−78℃〜室温が適当であり、特
に好ましくは−20℃〜0℃である。
The compound represented by the formula (III) can be synthesized by subjecting the compound represented by the formula (II) to a Diels-Alder reaction with cyclopentadiene in the presence of a Lewis acid catalyst. Examples of the catalyst used for the reaction include titanium tetrachloride and the like. As the reaction solvent, a halogen-based solvent such as methylene chloride, chloroform and dichloroethane, or a mixed solvent of these with a hydrocarbon-based solution such as pentane, hexane, heptane and petroleum ether can be used. The reaction temperature is suitably from -78 ° C to room temperature, particularly preferably from -20 ° C to 0 ° C.

【0014】式(III)で表される化合物は、塩基性条件
下に加水分解を行うことにより、式(IV)で表される化
合物に容易に変換することが出来る。反応に用いられる
塩基の例としては水酸化リチウム、水酸化ナトリウム、
水酸化カリウム等が挙げられる。反応溶媒としては、テ
トラヒドロフラン等のエーテル系溶媒、またはこれらと
メタノール、エタノール、ソルミックス等のアルコール
系溶媒との混合溶媒を用いることができる。反応温度は
0〜50℃が適当であり、特に好ましくは、20〜30℃付近
である。
The compound of the formula (III) can be easily converted to the compound of the formula (IV) by hydrolysis under basic conditions. Examples of the base used in the reaction include lithium hydroxide, sodium hydroxide,
Potassium hydroxide and the like. As the reaction solvent, an ether-based solvent such as tetrahydrofuran or a mixed solvent thereof with an alcohol-based solvent such as methanol, ethanol or solmix can be used. The reaction temperature is suitably from 0 to 50 ° C, particularly preferably around 20 to 30 ° C.

【0015】式(V)で表される化合物は、式(IV) で表
される化合物を接触水素添加することにより容易に得る
ことが出来る。反応に用いられる触媒の例としては、パ
ラジウム−炭素等が挙げられる。反応溶媒としては水、
メタノール、エタノール、ソルミックス等のアルコール
系溶媒、またはこれらの混合溶媒を用いることが出来
る。反応温度は0〜50℃が適当であり、好ましくは室温
である。
The compound represented by the formula (V) can be easily obtained by catalytic hydrogenation of the compound represented by the formula (IV). Examples of the catalyst used for the reaction include palladium-carbon and the like. Water, as a reaction solvent,
Alcohol solvents such as methanol, ethanol, and solmix, or a mixed solvent thereof can be used. The reaction temperature is suitably 0 to 50 ° C, preferably room temperature.

【0016】式(I)で表される化合物は、式(V)で表さ
れる化合物を酸化することにより得ることが出来る。反
応に用いられる酸化剤の例としては、過マンガン酸カリ
ウムが挙げられる。反応溶媒としては水、またはペンタ
ン、ヘキサン、ヘプタン、石油エーテル等の炭化水素系
溶媒と水との二相系を用いることが出来る。反応温度は
0〜100 ℃が適当であり、特に好ましくは室温〜70℃で
ある。
The compound represented by the formula (I) can be obtained by oxidizing the compound represented by the formula (V). Examples of the oxidizing agent used for the reaction include potassium permanganate. As a reaction solvent, water or a two-phase system of water and a hydrocarbon solvent such as pentane, hexane, heptane, petroleum ether and the like can be used. The reaction temperature is suitably from 0 to 100 ° C, particularly preferably from room temperature to 70 ° C.

【0017】以上の操作により、光学活性(+)−2−
ヒドロキシ−2−ノルボルナンカルボン酸(I) を製造す
ることが出来る。また、式 (II')で表される化合物を出
発物質とすることにより、同様にして光学活性(−)−
2−ヒドロキシ−2−ノルボルナンカルボン酸(I')を製
造することが出来る。
By the above operation, optical activity (+)-2-
Hydroxy-2-norbornanecarboxylic acid (I) can be produced. Similarly, by using the compound represented by the formula (II ') as a starting material, the optical activity (-)-
2-hydroxy-2-norbornanecarboxylic acid (I ') can be produced.

【0018】[0018]

【化9】 Embedded image

【0019】(R1、R2はアルキル基、アラルキル基、ア
リール基、シクロアルキル基を示す)を示す。〕。
(R 1 and R 2 represent an alkyl group, an aralkyl group, an aryl group or a cycloalkyl group). ].

【0020】[0020]

【発明の効果】本発明の式(I) または(I')で表される化
合物は本発明者らによって初めて合成された新規化合物
であり、様々な生理活性物質の合成中間体として利用で
きる。例えば、化合物(I) は次のようにして光学活性
(+)−2−ノルボルナノン(VI)に誘導することができ
る。即ち、化合物(I) をビスマス酸ナトリウム−リン
酸、四酢酸鉛、クロム酸−硫酸等の酸化剤を用いて酸化
することにより、式(VI)で表される化合物を得ることが
出来る。
The compound of the present invention represented by the formula (I) or (I ') is a novel compound synthesized for the first time by the present inventors and can be used as an intermediate for synthesizing various physiologically active substances. For example, compound (I) can be induced to optically active (+)-2-norbornanone (VI) as follows. That is, the compound represented by the formula (VI) can be obtained by oxidizing the compound (I) using an oxidizing agent such as sodium bismuthate-phosphoric acid, lead tetraacetate, and chromic acid-sulfuric acid.

【0021】式(VI)で表される化合物は、リチウムジイ
ソプロピルアミド(LDA) 、リチウムビス(トリメチルシ
リル)アミド等の塩基でエノール化した後に、ハロゲン
化アリルで捕捉することにより、式(VII) で表される化
合物に容易に変換することができる。化合物(VII) から
更に数段階を経ることにより、血液凝固阻止剤として有
用なトロンボキサンA2受容体アンタゴニスト(VIII)、(I
X)を得ることが出来る。
The compound represented by the formula (VI) is enolized with a base such as lithium diisopropylamide (LDA) or lithium bis (trimethylsilyl) amide and then trapped with an allyl halide to give a compound represented by the formula (VII). It can be easily converted to the represented compound. Through the further several steps from the compound (VII), useful thromboxane A 2 receptor antagonists as anticoagulant (VIII), (I
X) can be obtained.

【0022】[0022]

【化10】 Embedded image

【0023】[0023]

【実施例】以下、実施例及び参考例により本発明を更に
詳しく説明するが、本発明はこれらの実施例によって制
限されるものではない。 実施例1 (+)−2−ヒドロキシ−2−ノルボルナンカルボン酸
の製造 工程1 (S)−(−)−N−メチル−2−ヒドロキシコハク酸
イミド69.5g(538mmol)、トリエチルアミン70.8g(700m
mol)、塩化メチレン400ml の混合物に、−25℃にてアク
リル酸クロリド63.4g(700mmol) を滴下し、−20〜−25
℃で 4.5時間攪拌した。氷冷下、反応混合物に1N塩酸
170ml を加えて有機層を分離し、水層を塩化メチレン(2
00ml×3)で抽出した。有機層を合わせて飽和重曹水、
水、飽和食塩水(各150ml)で順次洗浄した。無水硫酸マ
グネシウム上で乾燥した後、溶媒を濾過、留去し、粗製
のアクリル酸エステル96.8gを得た。シリカゲルカラム
クロマトグラフィー(酢酸エチル)により精製し、
(S)−(−)−N−メチル−2−プロペノイルオキシ
コハク酸イミド72.2g(394mmol)を得た。収率73%。本
化合物は1H-NMRチャート解析により同定した。1H-NMR(C
DCl3) のデータを下記に示す。1 H-NMR: δ 2.6-3.5(m, 2H), 3.0(s, 3H), 5.5-5.7(m,
1H),5.8-6.7(m, 3H) 。
EXAMPLES The present invention will be described in more detail with reference to the following Examples and Reference Examples, but the present invention is not limited by these Examples. Example 1 Production of (+)-2-hydroxy-2-norbornanecarboxylic acid Step 1 (S)-(-)-N-methyl-2-hydroxysuccinimide 69.5 g (538 mmol), triethylamine 70.8 g (700 m
mol) and 400 ml of methylene chloride at −25 ° C., 63.4 g (700 mmol) of acrylic acid chloride was added dropwise at −25 to −25.
The mixture was stirred at ℃ for 4.5 hours. Under ice cooling, add 1N hydrochloric acid to the reaction mixture.
The organic layer was separated by adding 170 ml, and the aqueous layer was diluted with methylene chloride (2.
00 ml × 3). The combined organic layers are combined with saturated aqueous sodium bicarbonate,
Washed sequentially with water and saturated saline (150 ml each). After drying over anhydrous magnesium sulfate, the solvent was filtered and distilled off to obtain 96.8 g of a crude acrylic acid ester. Purified by silica gel column chromatography (ethyl acetate),
72.2 g (394 mmol) of (S)-(-)-N-methyl-2-propenoyloxysuccinimide was obtained. 73% yield. This compound was identified by 1 H-NMR chart analysis. 1 H-NMR (C
The data of DCl 3 ) are shown below. 1 H-NMR: δ 2.6-3.5 (m, 2H), 3.0 (s, 3H), 5.5-5.7 (m,
1H), 5.8-6.7 (m, 3H).

【0024】工程2 (S)−(−)−N−メチル−2−プロペノイルオキシ
コハク酸イミド72.2g(394mmol)を、塩化メチレン−石
油エーテル(7:1)混合溶媒580ml に溶解し、−15℃
にて四塩化チタン4.4ml (40.1mmol) (石油エーテル30ml
に溶解) を滴下した。−10〜−15℃で30分間攪拌した
後、用時調製したシクロペンタジエン32.4g(490mmol)
を滴下し、3.5 時間同温度で攪拌した。炭酸ナトリウム
10水塩50.1g(175mmol) の粉末を少量に分けて加えた
後、除々に昇温し、室温で1時間攪拌した。不溶物を濾
去し、濾上物を塩化メチレン(250ml×3)で洗浄した。
濾液を洗浄液と合わせて留去し、粗製のディールス・ア
ルダー付加体99.6gを得た。ヘプタン−酢酸エチル
(5:3)混合溶媒(600ml)から再結晶し、ディールス
・アルダー付加体67.0g(269mmol) を得た。収率68%。
本化合物は1H-NMRチャート解析により同定した。1H-NMR
(CDCl3) のデータを下記に示す。1 H-NMR δ: 1.2-2.2(m, 4H), 2.4-3.4(m, 5H), 3.0(s,
3H), 5.3-5.5(m, 1H),5.8-6.0(m, 1H), 6.1-6.3(m, 1
H)。
Step 2 72.2 g (394 mmol) of (S)-(-)-N-methyl-2-propenoyloxysuccinimide was dissolved in 580 ml of a mixed solvent of methylene chloride-petroleum ether (7: 1). 15 ℃
At 4.4 ml (40.1 mmol) of titanium tetrachloride (30 ml of petroleum ether)
) Was added dropwise. After stirring at -10 to -15 ° C for 30 minutes, 32.4 g (490 mmol) of cyclopentadiene prepared at the time of use was prepared.
Was added dropwise and stirred at the same temperature for 3.5 hours. sodium carbonate
After powder of 50.1 g (175 mmol) of decahydrate was added in small portions, the temperature was gradually increased, and the mixture was stirred at room temperature for 1 hour. The insoluble material was removed by filtration, and the residue was washed with methylene chloride (250 ml × 3).
The filtrate was combined with the washing solution and evaporated to obtain 99.6 g of a crude Diels-Alder adduct. Recrystallization from a heptane-ethyl acetate (5: 3) mixed solvent (600 ml) gave 67.0 g (269 mmol) of a Diels-Alder adduct. 68% yield.
This compound was identified by 1 H-NMR chart analysis. 1 H-NMR
(CDCl 3 ) data is shown below. 1 H-NMR δ: 1.2-2.2 (m, 4H), 2.4-3.4 (m, 5H), 3.0 (s,
3H), 5.3-5.5 (m, 1H), 5.8-6.0 (m, 1H), 6.1-6.3 (m, 1
H).

【0025】工程3 ディールス・アルダー付加体67.0g(269mmol) をテトラ
ヒドロフラン−水(5:2)混合溶媒1040mlに溶解し、
氷冷下、水酸化カリウム (85%) 70.5g(1.08mol) (水3
00ml に溶解) を加えて室温で24時間攪拌した。テトラ
ヒドロフランを留去した後、濃塩酸94mlで中和し、ヘキ
サン−塩化メチレン(98:2)混合溶媒(200ml ×4)
で抽出した。抽出液を無水硫酸マグネシウム上で乾燥し
た後、溶媒を濾過、留去して粗製の5−ノルボルネン−
2−カルボン酸38.8gを得た。粗収率100 %。本化合物
1H-NMRチャート解析により同定した。1H-NMR(CDCl3)
のデータを下記に示す。1 H-NMR: δ 1.1-1.6(m, 3H), 1.7-2.1(m, 1H), 2.7-3.3
(m, 3H),6.0(dd, 1H), 6.2(dd, 1H), 11.4(brs, 1H)。
Step 3 67.0 g (269 mmol) of the Diels-Alder adduct was dissolved in 1040 ml of a mixed solvent of tetrahydrofuran-water (5: 2).
Under ice cooling, potassium hydroxide (85%) 70.5 g (1.08 mol) (water 3
(Dissolved in 00 ml) and stirred at room temperature for 24 hours. After distilling off tetrahydrofuran, the mixture was neutralized with 94 ml of concentrated hydrochloric acid, and a mixed solvent of hexane-methylene chloride (98: 2) (200 ml × 4).
Extracted. After the extract was dried over anhydrous magnesium sulfate, the solvent was filtered and distilled off to give crude 5-norbornene-
38.8 g of 2-carboxylic acid were obtained. Crude yield 100%. This compound was identified by 1 H-NMR chart analysis. 1 H-NMR (CDCl 3 )
Are shown below. 1 H-NMR: δ 1.1-1.6 (m, 3H), 1.7-2.1 (m, 1H), 2.7-3.3
(m, 3H), 6.0 (dd, 1H), 6.2 (dd, 1H), 11.4 (brs, 1H).

【0026】工程4 粗製の5−ノルボルネン−2−カルボン酸 38.8g(269mm
ol) を、ソルミックス740 mlに溶解し、5%パラジウム
−カーボン粉末1.92gを加えて、水素雰囲気下で17.5時
間攪拌した。触媒を濾去した後、溶媒を留去し、粗製の
2−ノルボルナンカルボン酸38.0gを得た。粗収率100
%。本化合物は1H-NMRチャート解析により同定した。1H
-NMR(CDCl3) のデータを下記に示す。1 H-NMR: δ 1.1-1.9(m, 8H), 2.2-2.4(m, 1H), 2.5-3.0
(m, 2H),11.0(brs, 1H)。
Step 4 38.8 g (269 mm) of crude 5-norbornene-2-carboxylic acid
ol) was dissolved in 740 ml of Solmix, and 1.92 g of 5% palladium-carbon powder was added, followed by stirring under a hydrogen atmosphere for 17.5 hours. After removing the catalyst by filtration, the solvent was distilled off to obtain 38.0 g of crude 2-norbornanecarboxylic acid. Crude yield 100
%. This compound was identified by 1 H-NMR chart analysis. 1 H
-NMR (CDCl 3 ) data are shown below. 1 H-NMR: δ 1.1-1.9 (m, 8H), 2.2-2.4 (m, 1H), 2.5-3.0
(m, 2H), 11.0 (brs, 1H).

【0027】工程5 水酸化カリウム (85%) 107g (1.63mmol) 、過マンガン
酸カリウム85.7g(542mmol) を水380ml に溶解し、氷冷
下、粗製の2−ノルボルナンカルボン酸37.9g(271mmo
l) の石油エーテル溶液380ml を滴下した。8時間加熱
還流した後、室温で18時間攪拌した。氷冷下、反応混合
物を6N硫酸 544ml中にゆっくりと加えて酸性にした
後、亜硫酸水素ナトリウム62.2gの水溶液272ml を加え
て室温で1時間攪拌した。酢酸エチル(200ml×4) で抽
出し、抽出液を無水硫酸マグネシウム上で乾燥した。溶
媒を濾過、留去し、粗製の(+)−2−ヒドロキシ−2
−ノルボルナンカルボン酸38.5gを得た。粗収率92%。
Step 5 107 g (1.63 mmol) of potassium hydroxide (85%) and 85.7 g (542 mmol) of potassium permanganate are dissolved in 380 ml of water, and 37.9 g (271 mmo) of crude 2-norbornanecarboxylic acid is cooled under ice-cooling.
380 ml of a petroleum ether solution of l) were added dropwise. After heating under reflux for 8 hours, the mixture was stirred at room temperature for 18 hours. Under ice-cooling, the reaction mixture was slowly added to 544 ml of 6N sulfuric acid to make it acidic, and thereto was added 272 ml of an aqueous solution of 62.2 g of sodium bisulfite, followed by stirring at room temperature for 1 hour. The mixture was extracted with ethyl acetate (200 ml × 4), and the extract was dried over anhydrous magnesium sulfate. The solvent was filtered off and evaporated to give crude (+)-2-hydroxy-2.
38.5 g of norbornanecarboxylic acid were obtained. Crude yield 92%.

【0028】本化合物は1H-NMRチャート解析により同定
した。1H-NMR(CDCl3) のデータを下記に示す。1 H-NMR: δ 1.0-2.3(m, 10H), 7.4(brs, 2H)。 本化合物の立体配置は、参考例1にて得られた2−ノル
ボルナノンの旋光度の符号を文献値(Narisadaら、J. M
ed. Chem.,31, 1847(1988)) と比較することにより決定
した。
The compound was identified by 1 H-NMR chart analysis. 1 H-NMR (CDCl 3 ) data is shown below. 1 H-NMR: δ 1.0-2.3 (m, 10H), 7.4 (brs, 2H). The steric configuration of the present compound is determined by comparing the sign of the optical rotation of 2-norbornanone obtained in Reference Example 1 with a literature value (Narisada et al., J. M.
ed. Chem., 31 , 1847 (1988)).

【0029】実施例2 5−ノルボルネン−2−カルボン酸の製造 工程1 (S)−乳酸エチル59.0g(499mmol)、トリエチルアミ
ン55.7g(550mmol)、ジクロロエタン200ml の混合物
に、−20℃にてアクリル酸クロリド49.8g(550mmol)(ジ
クロロエタン100ml に溶解) を滴下し、−20℃で4.5 時
間攪拌した。氷冷下、反応混合物に1N塩酸を加えて有
機層を分離し、水層を塩化メチレンで抽出した。有機層
を合わせて飽和重曹水、水で順次洗浄した。無水硫酸マ
グネシウム上で乾燥後、溶媒を濾過して留去し、粗製の
(S)−エチル 2−プロペノイルオキシプロピオン酸
エステル75.0gを得た。
Example 2 Production of 5-norbornene-2-carboxylic acid Step 1 A mixture of 59.0 g (499 mmol) of (S) -ethyl lactate, 55.7 g (550 mmol) of triethylamine, and 200 ml of dichloroethane was added to acrylic acid at -20 ° C. 49.8 g (550 mmol) of chloride (dissolved in 100 ml of dichloroethane) was added dropwise, and the mixture was stirred at -20 ° C for 4.5 hours. Under ice cooling, 1N hydrochloric acid was added to the reaction mixture, the organic layer was separated, and the aqueous layer was extracted with methylene chloride. The organic layers were combined and washed sequentially with saturated aqueous sodium hydrogen carbonate and water. After drying over anhydrous magnesium sulfate, the solvent was filtered off and evaporated to obtain 75.0 g of crude (S) -ethyl 2-propenoyloxypropionate.

【0030】工程2 粗製の(S)−エチル 2−プロペノイルオキシプロピ
オン酸エステル67.5g(382mmol) を塩化メチレン150ml
に溶解し、−20℃にて四塩化チタン5.0ml(45.6mmol)(ヘ
キサン30mlに溶解) を滴下した。−10℃で30分間攪拌し
た後、用時調製したシクロペンタジエン31.1g (470mmo
l)(塩化メチレン50mlに溶解) を滴下し、2時間同温度
で攪拌した。炭酸ナトリウム10水塩20.0g(69.9mmol)の
粉末を少量に分けて加えた後、除々に昇温し、室温で1
晩攪拌した。不溶物を濾去し、濾上物を塩化メチレンで
洗浄した。濾液を洗浄液と合わせて飽和重曹水、水で順
次洗浄した。無水硫酸マグネシウム上で乾燥後、溶媒を
濾過して留去し、粗製のディールス・アルダー付加体9
5.0gを定量的に得た。本化合物は1H-NMRチャート解析
により同定した。1H-NMR(CDCl3) のデータを下記に示
す。1 H-NMR δ: 1.2-1.5(m, 10H), 2.6-3.1(m, 3H), 4.3(q,
2H), 5.1(q, 1H),6.0-6.2(m, 2H)。
Step 2 67.5 g (382 mmol) of crude (S) -ethyl 2-propenoyloxypropionate were added to 150 ml of methylene chloride.
And 5.0 ml (45.6 mmol) of titanium tetrachloride (dissolved in 30 ml of hexane) was added dropwise at -20 ° C. After stirring at −10 ° C. for 30 minutes, 31.1 g (470 mmo) of cyclopentadiene prepared at the time of use was prepared.
l) (dissolved in 50 ml of methylene chloride) was added dropwise and stirred at the same temperature for 2 hours. After adding powder of 20.0 g (69.9 mmol) of sodium carbonate decahydrate in a small amount, the temperature was gradually increased, and the temperature was increased to 1 at room temperature.
Stirred overnight. The insoluble material was removed by filtration, and the residue was washed with methylene chloride. The filtrate was combined with the washing solution and washed sequentially with saturated aqueous sodium hydrogen carbonate and water. After drying over anhydrous magnesium sulfate, the solvent was removed by filtration and the crude Diels-Alder adduct 9
5.0 g were obtained quantitatively. This compound was identified by 1 H-NMR chart analysis. 1 H-NMR (CDCl 3 ) data is shown below. 1 H-NMR δ: 1.2-1.5 (m, 10H), 2.6-3.1 (m, 3H), 4.3 (q,
2H), 5.1 (q, 1H), 6.0-6.2 (m, 2H).

【0031】工程3 ディールス・アルダー付加体 95.0g (392mmol)をテトラ
ヒドロフラン950ml に溶解し、氷冷下、水酸化カリウム
(85%)103g(1.57mol)(水760ml に溶解) を加えて室温
で24時間攪拌した。テトラヒドロフランを留去した後、
濃塩酸138 mlで中和し、ヘキサン−塩化メチレン(98:
2)混合溶媒(200ml×4)で抽出した。抽出液を無水硫
酸マグネシウム上で乾燥した後、溶媒を濾過、留去して
粗製の5−ノルボルネン−2−カルボン酸45.0gを得
た。粗収率83%。
Step 3 95.0 g (392 mmol) of the Diels-Alder adduct was dissolved in 950 ml of tetrahydrofuran, and 103 g (1.57 mol) of potassium hydroxide (85%) (1.57 mol) (dissolved in 760 ml of water) was added under ice-cooling. Stirred for hours. After distilling off tetrahydrofuran,
Neutralized with 138 ml of concentrated hydrochloric acid, hexane-methylene chloride (98:
2) The mixture was extracted with a mixed solvent (200 ml × 4). After the extract was dried over anhydrous magnesium sulfate, the solvent was filtered and evaporated to obtain 45.0 g of crude 5-norbornene-2-carboxylic acid. 83% crude yield.

【0032】本化合物は1H-NMRチャート解析により同定
した。1H-NMR(CDCl3) のデータを下記に示す。1 H-NMR:δ 1.1-1.6(m, 3H), 1.7-2.1(m, 1H), 2.7-3.3
(m, 3H),6.0(dd, 1H), 6.2(dd, 1H), 11.4(brs, 1H)。 かくして得られた粗製の5−ノルボルネン−2−カルボ
ン酸は、実施例1の工程4で用いられた粗製の5−ノル
ボルネン−2−カルボン酸に代えて用いることができ、
同工程4及び5を経て、粗製の(+)−2−ヒドロキシ
−2−ノルボルナンカルボン酸を与えることができる。
This compound was identified by 1 H-NMR chart analysis. 1 H-NMR (CDCl 3 ) data is shown below. 1 H-NMR: δ 1.1-1.6 (m, 3H), 1.7-2.1 (m, 1H), 2.7-3.3
(m, 3H), 6.0 (dd, 1H), 6.2 (dd, 1H), 11.4 (brs, 1H). The crude 5-norbornene-2-carboxylic acid thus obtained can be used in place of the crude 5-norbornene-2-carboxylic acid used in Step 4 of Example 1,
Through the same steps 4 and 5, crude (+)-2-hydroxy-2-norbornanecarboxylic acid can be obtained.

【0033】実施例3 (+)−2−ヒドロキシ−2−ノルボルナンカルボン酸
の製造 工程1 実施例1の工程2より得られるディールス・アルダー付
加体5.00g(20.0mmol)をテトラヒドロフラン−水(5:
4)混合溶媒45mlに懸濁し、氷冷下、水酸化ナトリウム
(93 %)1.85g(43.0mmol) を加えて室温で24時間攪拌し
た。テトラヒドロフランを留去した後、濃塩酸で中和し
た。続いて5%パラジウム−カーボン粉末280mg を加え
て、水素雰囲気下で30時間攪拌した。触媒を濾去し、濃
塩酸で酸性とした後、ヘキサン−塩化メチレン(98:
2)混合溶媒(50ml×4)で抽出した。抽出液を無水硫
酸マグネシウム上で乾燥した後、溶媒を濾過、留去して
粗製の2−ノルボルナンカルボン酸2.66g を得た。粗収
率95%。本化合物は1H-NMRチャート解析により同定し
た。
Example 3 Production of (+)-2-hydroxy-2-norbornanecarboxylic acid Step 1 5.00 g (20.0 mmol) of the Diels-Alder adduct obtained from Step 2 of Example 1 was added to tetrahydrofuran-water (5:
4) Suspend in 45 ml of a mixed solvent and add sodium hydroxide under ice-cooling.
(93%) 1.85 g (43.0 mmol) was added and the mixture was stirred at room temperature for 24 hours. After distilling off tetrahydrofuran, the mixture was neutralized with concentrated hydrochloric acid. Subsequently, 280 mg of 5% palladium-carbon powder was added, and the mixture was stirred under a hydrogen atmosphere for 30 hours. After removing the catalyst by filtration and acidifying with concentrated hydrochloric acid, hexane-methylene chloride (98:
2) The mixture was extracted with a mixed solvent (50 ml × 4). After the extract was dried over anhydrous magnesium sulfate, the solvent was filtered and distilled off to obtain 2.66 g of crude 2-norbornanecarboxylic acid. 95% crude yield. This compound was identified by 1 H-NMR chart analysis.

【0034】工程2 粗製の2−ノルボルナンカルボン酸 1.83g(13.1mmol)を
水10mlに溶解し、氷冷下、水酸化カリウム (85%)0.87
g(13.1mmol) を加えて6時間攪拌した。この反応液を水
酸化カリウム(85%)5.22g(79.5mmol) 、過マンガン酸
カリウム4.57g(28.9mmol)、水10ml、ヘキサン20mlの混
合物中に滴下した。40〜50℃にて8時間加熱攪拌した
後、室温で18時間攪拌した。実施例1の工程5と同様に
して後処理し粗製の(+)−2−ヒドロキシ−2−ノル
ボルナンカルボン酸 1.74gを得た。粗収率85%。本化合
物は1H-NMRチャート解析により同定した。
Step 2 1.83 g (13.1 mmol) of crude 2-norbornanecarboxylic acid was dissolved in 10 ml of water, and 0.87 g of potassium hydroxide (85%) was added under ice-cooling.
g (13.1 mmol) was added and stirred for 6 hours. This reaction solution was added dropwise to a mixture of 5.22 g (79.5 mmol) of potassium hydroxide (85%), 4.57 g (28.9 mmol) of potassium permanganate, 10 ml of water and 20 ml of hexane. After heating and stirring at 40 to 50 ° C for 8 hours, the mixture was stirred at room temperature for 18 hours. Post-treatment was carried out in the same manner as in Step 5 of Example 1 to obtain 1.74 g of crude (+)-2-hydroxy-2-norbornanecarboxylic acid. 85% crude yield. This compound was identified by 1 H-NMR chart analysis.

【0035】実施例4 (+)−2−ヒドロキシ−2−ノルボルナンカルボン酸
の製造 工程1 実施例1の工程2より得られるディールス・アルダー付
加体5.00g (20.0mmol)をテトラヒドロフラン−メタノー
ル(1:1)混合溶媒40mlに懸濁し、氷冷下、水酸化ナ
トリウム (93%)1.86g (43.3mmol) (水4mlに溶解) を
加えて室温で24時間攪拌した。続いて5%パラジウム−
カーボン粉末280mg を加えて水素雰囲気下で5時間攪拌
した。触媒を濾去し、溶媒を留去した後、水で希釈し
た。濃塩酸で酸性とした後、ヘキサン−塩化メチレン
(98:2)混合溶媒(50ml×4) で抽出した。抽出液を
無水硫酸マグネシウム上で乾燥した後、溶媒を濾過、留
去して粗製の2−ノルボルナンカルボン酸2.67g を得
た。粗収率95%。本化合物は1H-NMRチャート解析により
同定した。
Example 4 Preparation of (+)-2-hydroxy-2-norbornanecarboxylic acid Step 1 5.00 g (20.0 mmol) of the Diels-Alder adduct obtained from Step 2 of Example 1 was added to tetrahydrofuran-methanol (1: 2). 1) Suspended in 40 ml of a mixed solvent, 1.86 g (43.3 mmol) of sodium hydroxide (93%) (dissolved in 4 ml of water) was added under ice cooling, and the mixture was stirred at room temperature for 24 hours. Then 5% palladium-
280 mg of carbon powder was added, and the mixture was stirred under a hydrogen atmosphere for 5 hours. The catalyst was removed by filtration, the solvent was distilled off, and the mixture was diluted with water. After acidification with concentrated hydrochloric acid, the mixture was extracted with a mixed solvent of hexane-methylene chloride (98: 2) (50 ml × 4). After the extract was dried over anhydrous magnesium sulfate, the solvent was filtered and distilled off to obtain 2.67 g of crude 2-norbornanecarboxylic acid. 95% crude yield. This compound was identified by 1 H-NMR chart analysis.

【0036】工程2 粗製の2−ノルボルナンカルボン酸9.59g(68.4mmol) を
水50mlに溶解し、氷冷下、水酸化カリウム (85%)4.55
g (68.9mmol)を加えて6時間攪拌した。この反応液を水
酸化カリウム(85%)30.0g (456mmol) 、過マンガン酸
カリウム23.4g(148mmol) 、水50mlの混合物中に滴下し
た。40〜50℃で9時間加熱攪拌した後、室温で18時間攪
拌した。実施例1の工程5と同様にして後処理し、粗製
の(+)−2−ヒドロキシ−2−ノルボルナンカルボン
酸9.51g を得た。粗収率89%。本化合物は1H-NMRチャー
ト解析により同定した。
Step 2 Crude 2-norbornanecarboxylic acid (9.59 g, 68.4 mmol) was dissolved in water (50 ml), and potassium hydroxide (85%) 4.55 was added under ice-cooling.
g (68.9 mmol) was added and stirred for 6 hours. This reaction solution was added dropwise to a mixture of 30.0 g (456 mmol) of potassium hydroxide (85%), 23.4 g (148 mmol) of potassium permanganate, and 50 ml of water. After heating and stirring at 40 to 50 ° C for 9 hours, the mixture was stirred at room temperature for 18 hours. Post-treatment was conducted in the same manner as in Step 5 of Example 1 to obtain 9.51 g of crude (+)-2-hydroxy-2-norbornanecarboxylic acid. 89% crude yield. This compound was identified by 1 H-NMR chart analysis.

【0037】参考例1 (+)−2−ノルボルナノンの製造 実施例1の工程5より得られる粗製の(+)−2−ヒド
ロキシ−2−ノルボルナンカルボン酸 38.5g (247mmo
l)、ビスマス酸ナトリウム (80%)90.6g (259mmol)
を、水400ml に溶解し、リン酸 (85%)83.9g (728mmo
l) を滴下して、45〜50℃で6時間、室温で18時間攪拌
した。酢酸エチル(200ml×4)で抽出し、抽出液を飽和
重曹水、水、飽和食塩水 (各200ml)で順次洗浄後、無水
硫酸マグネシウム上で乾燥した。酢酸エチルを常圧下に
留去した後、蒸留し、(+)−2−ノルボルナノン14.8
g (134mmol) を得た。収率50%。
Reference Example 1 Production of (+)-2-norbornanone 38.5 g of crude (+)-2-hydroxy-2-norbornanecarboxylic acid obtained from step 5 of Example 1 (247 mmo)
l), sodium bismuthate (80%) 90.6g (259mmol)
Is dissolved in 400 ml of water, and 83.9 g of phosphoric acid (85%) (728 mmo)
l) was added dropwise, and the mixture was stirred at 45 to 50 ° C for 6 hours and at room temperature for 18 hours. The mixture was extracted with ethyl acetate (200 ml × 4), and the extract was washed successively with saturated aqueous sodium hydrogen carbonate, water, and saturated saline (200 ml each), and dried over anhydrous magnesium sulfate. After the ethyl acetate was distilled off under normal pressure, the residue was distilled to obtain (+)-2-norbornanone (14.8).
g (134 mmol) were obtained. Yield 50%.

【0038】本化合物は1H-NMRチャート解析により同定
した。1H-NMR(CDCl3) のデータを下記に示す。1 H-NMR: δ 1.2-2.3(m, 8H), 2.5-2.9(m, 2H) また、物性値は以下の通りであった。 沸点:174 ℃ 比旋光度:[α]D +29.0° (cl.51, CHCl3) 文献値;[α]D 24+28.5± 0.5° (cl.5, CHCl3) (J. Med. Chem.,31,1847(1988)) 。
This compound was identified by 1 H-NMR chart analysis. 1 H-NMR (CDCl 3 ) data is shown below. 1 H-NMR: δ 1.2-2.3 (m, 8H), 2.5-2.9 (m, 2H) The physical properties were as follows. Boiling point: 174 ° C Specific rotation: [α] D + 29.0 ° (cl.51, CHCl 3 ) Literature; [α] D 24 + 28.5 ± 0.5 ° (cl.5, CHCl 3 ) (J. Med Chem., 31 , 1847 (1988)).

【0039】実施例5 (−)−2−ヒドロキシ−2−ノルボルナンカルボン酸
の製造 工程1 (R)−(−)−パントイルラクトン46.8g(360mmol)、
トリエチルアミン 54.7g(541mmol) 、塩化メチレン 300
mlの混合物に、−25℃にて、アクリル酸クロリド41.2g
(455mmol) を滴下し、−20〜−25℃で5時間攪拌した。
氷冷下、反応混合物に0.5N塩酸500ml を加えて有機層を
分離し、水層を塩化メチレン(150ml×3)で抽出した。
有機層を合わせて飽和重曹水、水、飽和食塩水(各250m
l)で順次洗浄した。無水硫酸マグネシウム上で乾燥後、
溶媒を濾過、留去し、粗製のアクリル酸エステル64.5g
を得た。シリカゲルカラムクロマトグラフィー(ヘキサ
ン−酢酸エチル3:1)により精製し、(R)−ジヒド
ロ−3−プロペノイルオキシ−4, 4−ジメチル−2 (3H)
−フラノン61.3g (333mmol) を得た。収率93%。本化合
物は1H-NMRチャート解析により同定した。1H-NMR(CDC
l3) のデータを下記に示す。1 H-NMR:δ 1.1(s. 3H), 1.3(s, 3H), 4.0(s, 2H), 5.5
(s, 1H)5.9-6.7(m, 3H) 。
Example 5 Preparation of (-)-2-hydroxy-2-norbornanecarboxylic acid Step 1 46.8 g (360 mmol) of (R)-(-)-pantoyl lactone,
54.7 g (541 mmol) of triethylamine, methylene chloride 300
To a mixture of ml, at −25 ° C., 41.2 g of acrylic acid chloride
(455 mmol) was added dropwise, and the mixture was stirred at -20 to -25 ° C for 5 hours.
Under ice-cooling, 500 ml of 0.5N hydrochloric acid was added to the reaction mixture to separate the organic layer, and the aqueous layer was extracted with methylene chloride (150 ml × 3).
The combined organic layers are combined with saturated aqueous sodium bicarbonate, water, and saturated saline (250 m each)
Washing was performed sequentially in l). After drying over anhydrous magnesium sulfate,
The solvent was filtered and evaporated, and the crude acrylic ester 64.5 g
I got Purification by silica gel column chromatography (hexane-ethyl acetate 3: 1), (R) -dihydro-3-propenoyloxy-4,4-dimethyl-2 (3H)
61.3 g (333 mmol) of furanone were obtained. 93% yield. This compound was identified by 1 H-NMR chart analysis. 1 H-NMR (CDC
l The data of 3 ) is shown below. 1 H-NMR: δ 1.1 (s. 3H), 1.3 (s, 3H), 4.0 (s, 2H), 5.5
(s, 1H) 5.9-6.7 (m, 3H).

【0040】工程2 (R)−ジヒドロ−3−プロペノイルオキシ−4, 4−ジ
メチル−2(3H) −フラノン 25.1g(136mmol)を塩化メチ
レン−石油エーテル(7:1)混合溶媒200ml に溶解
し、−15℃にて四塩化チタン 1.6ml(14.6mmol)(石油エ
ーテル10mlに溶解)を滴下した。−10〜−15℃で30分間
攪拌した後、用時調製したシクロペンタジエン 11.9g
(180mmol)を滴下し、3時間同温度で攪拌した。炭酸ナ
トリウム10水塩17.3g (60.4mmol)の粉末を少量に分けて
加えた後、除々に昇温し室温で30分間攪拌した。不溶物
を濾去し、濾上物を塩化メチレン(100ml×3)で洗浄し
た。濾液を洗浄液と合わせて留去し、粗製のディールス
・アルダー付加体34.0g を得た。ヘキサン−酢酸エチル
(5:3)混合溶媒(125ml)から再結晶し、ディールス
・アルダー付加体 27.5g(110mmol) を得た。収率81%。
本化合物は1H-NMRチャート解析により同定した。1H-NMR
(CDCl3) のデータを下記に示す。1 H-NMR:δ 1.0-2.2(m, 4H), 1.1(s, 3H), 1.2(s, 3H),
2.8-3.3(m, 3H),4.0(s, 2H), 5.3(s, 1H), 5.8-6.0(m,
1H), 6.2-6.4(m, 1H) 。
Step 2 25.1 g (136 mmol) of (R) -dihydro-3-propenoyloxy-4,4-dimethyl-2 (3H) -furanone was dissolved in 200 ml of a mixed solvent of methylene chloride and petroleum ether (7: 1). Then, 1.6 ml (14.6 mmol) of titanium tetrachloride (dissolved in 10 ml of petroleum ether) was added dropwise at -15 ° C. After stirring at -10 to -15 ° C for 30 minutes, 11.9 g of cyclopentadiene prepared before use
(180 mmol) was added dropwise, and the mixture was stirred at the same temperature for 3 hours. After powder of 17.3 g (60.4 mmol) of sodium carbonate decahydrate was added in small portions, the temperature was gradually increased and the mixture was stirred at room temperature for 30 minutes. The insoluble material was removed by filtration, and the residue was washed with methylene chloride (100 ml × 3). The filtrate was combined with the washing solution and evaporated to obtain 34.0 g of a crude Diels-Alder adduct. Recrystallization from a hexane-ethyl acetate (5: 3) mixed solvent (125 ml) gave 27.5 g (110 mmol) of a Diels-Alder adduct. Yield 81%.
This compound was identified by 1 H-NMR chart analysis. 1 H-NMR
(CDCl 3 ) data is shown below. 1 H-NMR: δ 1.0-2.2 (m, 4H), 1.1 (s, 3H), 1.2 (s, 3H),
2.8-3.3 (m, 3H), 4.0 (s, 2H), 5.3 (s, 1H), 5.8-6.0 (m,
1H), 6.2-6.4 (m, 1H).

【0041】工程3 ディールス・アルダー付加体 27.5g (110mmol)をテトラ
ヒドロフラン−水(5:2)混合溶媒420ml に溶解し、
氷冷下、水酸化カリウム(85%)30.0g (455mmol)(水12
0ml に溶解) を加えて、室温で24時間攪拌した。テトラ
ヒドロフランを留去した後、濃塩酸40mlで中和し、ヘキ
サン−塩化メチレン(98:2)混合溶媒(150ml×4)で
抽出した。抽出液を無水硫酸マグネシウム上で乾燥した
後、溶媒を濾過、留去して粗製の5−ノルボルネン−2
−カルボン酸15.7g を得た。粗収率 100%。
Step 3 27.5 g (110 mmol) of the Diels-Alder adduct was dissolved in 420 ml of a mixed solvent of tetrahydrofuran-water (5: 2).
Under ice cooling, potassium hydroxide (85%) 30.0 g (455 mmol) (water 12
(Dissolved in 0 ml) and stirred at room temperature for 24 hours. After distilling off tetrahydrofuran, the mixture was neutralized with 40 ml of concentrated hydrochloric acid and extracted with a mixed solvent of hexane-methylene chloride (98: 2) (150 ml × 4). After the extract was dried over anhydrous magnesium sulfate, the solvent was filtered and distilled off to give crude 5-norbornene-2.
15.7 g of carboxylic acid were obtained. Crude yield 100%.

【0042】本化合物は1H-NMRチャート解析により同定
した。1H-NMR(CDCl3) のデータを下記に示す。1 H-NMR:δ 1.1-1.6(m, 3H), 1.7-2.1(m, 1H), 2.7-3.3
(m, 3H),6.0(dd, 1H), 6.2(dd, 1H), 11.4(brs, 1H)。 工程4 粗製の5−ノルボルネン−2−カルボン酸 15.7g (110m
mol)をエタノール300mlに溶解し、5%パラジウム−カ
ーボン粉末1.55g を加えて水素雰囲気下で24時間攪拌し
た。触媒を濾去した後、溶媒を留去し、粗製の2−ノル
ボルナンカルボン酸 14.5gを得た。粗収率94%。本化合
物は1H-NMRチャート解析により同定した。1H-NMR(CDC
l3) のデータを下記に示す。1 H-NMR:δ 1.1-1.9(m, 8H), 2.2-2.4(m, 1H), 2.5-3.0
(m, 2H),11.0(brs, 1H)。
The compound was identified by 1 H-NMR chart analysis. 1 H-NMR (CDCl 3 ) data is shown below. 1 H-NMR: δ 1.1-1.6 (m, 3H), 1.7-2.1 (m, 1H), 2.7-3.3
(m, 3H), 6.0 (dd, 1H), 6.2 (dd, 1H), 11.4 (brs, 1H). Step 4 15.7 g of crude 5-norbornene-2-carboxylic acid (110 m
mol) was dissolved in 300 ml of ethanol, 1.55 g of 5% palladium-carbon powder was added, and the mixture was stirred under a hydrogen atmosphere for 24 hours. After filtering off the catalyst, the solvent was distilled off to obtain 14.5 g of crude 2-norbornanecarboxylic acid. Crude yield 94%. This compound was identified by 1 H-NMR chart analysis. 1 H-NMR (CDC
l The data of 3 ) is shown below. 1 H-NMR: δ 1.1-1.9 (m, 8H), 2.2-2.4 (m, 1H), 2.5-3.0
(m, 2H), 11.0 (brs, 1H).

【0043】工程5 水酸化カリウム(85%)24.1g (367mmol) 、過マンガン
酸カリウム 18.9g(120mmol) を水84mlに溶解し、氷冷
下、粗製の2−ノルボルナンカルボン酸 8.36g(59.6mmo
l)の石油エーテル溶液84mlを滴下した。6時間加熱還流
した後、室温で18時間攪拌した。氷冷下、反応混合物を
6N硫酸 120ml中にゆっくりと加えて酸性にした後、亜
硫酸水素ナトリウム 13.0gの水溶液60mlを加えて室温で
1時間攪拌した。エーテル(100ml×4)で抽出し、抽出
液を無水硫酸マグネシウム上で乾燥した。溶媒を濾過、
留去し、粗製の(−)−2−ヒドロキシ−2−ノルボル
ナンカルボン酸8.34g を得た。粗収率90%。
Step 5 24.1 g (367 mmol) of potassium hydroxide (85%) and 18.9 g (120 mmol) of potassium permanganate are dissolved in 84 ml of water, and 8.36 g (59.6 mmol) of crude 2-norbornanecarboxylic acid is cooled under ice-cooling.
84 ml of petroleum ether solution of l) were added dropwise. After heating under reflux for 6 hours, the mixture was stirred at room temperature for 18 hours. Under ice cooling, the reaction mixture was slowly added to 120 ml of 6N sulfuric acid to make it acidic, and then 60 ml of an aqueous solution of 13.0 g of sodium hydrogen sulfite was added, followed by stirring at room temperature for 1 hour. The mixture was extracted with ether (100 ml × 4), and the extract was dried over anhydrous magnesium sulfate. Filter the solvent,
Evaporation gave 8.34 g of crude (-)-2-hydroxy-2-norbornanecarboxylic acid. 90% crude yield.

【0044】本化合物は1H-NMRチャート解析により同定
した。1H-NMR(CDCl3) のデータを下記に示す。1 H-NMR:δ 1.0-2.3(m, 10H), 7.4(brs, 2H) 本化合物の立体配置は、参考例2にて得られた(−)−
2−ノルボルナノンの旋光度の符号を文献値(Narisada
ら、J. Med. Chem.,31, 1847(1988)) と比較することに
より決定した。
This compound was identified by 1 H-NMR chart analysis. 1 H-NMR (CDCl 3 ) data is shown below. 1 H-NMR: δ 1.0-2.3 (m, 10H), 7.4 (brs, 2H) The configuration of this compound was obtained by (−)-in Reference Example 2.
The sign of the optical rotation of 2-norbornanone is shown in the literature (Narisada
J. Med. Chem., 31 , 1847 (1988)).

【0045】参考例2 (−)−2−ノルボルナノンの製造 実施例4の工程5で得られた粗製の(−)−2−ヒドロ
キシ−2−ノルボルナンカルボン酸 8.25g (52.8mmol)
、ビスマス酸ナトリウム(80%) 19.5g (55.7mmol)を
水85mlに溶解し、リン酸(85%)18.0g (156mmol) を滴
下して、45〜50℃で8時間、室温で18時間攪拌した。エ
ーテル(100ml×4)で抽出し、抽出液を飽和重曹水、
水、飽和食塩水(各100ml)で順次洗浄後、無水硫酸マグ
ネシウム上で乾燥した。エーテルを常圧下留去した後、
蒸留し、(−)−2−ノルボルナノン3.09g (28.1mmol)
を得た。収率53%。
Reference Example 2 Production of (-)-2-norbornanone 8.25 g (52.8 mmol) of the crude (-)-2-hydroxy-2-norbornanecarboxylic acid obtained in Step 5 of Example 4.
Then, 19.5 g (55.7 mmol) of sodium bismuthate (80%) was dissolved in 85 ml of water, 18.0 g (156 mmol) of phosphoric acid (85%) was added dropwise, and the mixture was stirred at 45 to 50 ° C for 8 hours and at room temperature for 18 hours. did. Extract with ether (100 ml x 4), extract the extract with saturated aqueous sodium bicarbonate,
After washing with water and saturated saline solution (100 ml each), the mixture was dried over anhydrous magnesium sulfate. After ether was distilled off under normal pressure,
After distillation, 3.09 g (28.1 mmol) of (−)-2-norbornanone
I got Yield 53%.

【0046】本化合物は1H-NMRチャート解析により同定
した。1H-NMR(CDCl3) のデータを下記に示す。1 H-NMR:δ 1.2-2.3(m, 8H), 2.5-2.9(m, 2H) また、物性値は以下の通りであった。 沸点:174 ℃ 比旋光度:[α]D −28.5° (cl.55, CHCl3) 文献値;[α]D 24−28.6± 0.3° (c2.2, CHCl3) (J. Med. Chem.,31,1847(1988)) 。
This compound was identified by 1 H-NMR chart analysis. 1 H-NMR (CDCl 3 ) data is shown below. 1 H-NMR: δ 1.2-2.3 (m, 8H), 2.5-2.9 (m, 2H) The physical properties were as follows. Boiling point: 174 ° C Specific rotation: [α] D −28.5 ° (cl.55, CHCl 3 ) Literature; [α] D 24 −28.6 ± 0.3 ° (c2.2, CHCl 3 ) (J. Med. Chem.) ., 31 , 1847 (1988)).

───────────────────────────────────────────────────── フロントページの続き (56)参考文献 米国特許3931198(US,A) 米国特許3720681(US,A) ”Tetrahedron Let t.”(1985),Vol.26,No. 7,pages 811−814 ”Tetrahedron Let t.”(1981),Vol.22,No. 34,pages 3231−3234 ”Org.Prep.Proced. Int.”(1980),Vol.12,N o.6,pages 357−360 ”CHEMISTRY LETTER S”(1978),No.1,pages 49−50 (58)調査した分野(Int.Cl.7,DB名) C07C 62/06 B01J 23/44 B01J 27/10 C07C 51/367 C07B 61/00 300 CA(STN) REGISTRY(STN)────────────────────────────────────────────────── ─── Continuation of the front page (56) Reference US Pat. No. 3,931,984 (US, A) US Pat. 26, No. 7, pages 811-814 "Tetrahedron Lett." (1981), Vol. 22, No. 34, pages 3231-3234 "Org. Prep. Proced. Int." (1980), Vol. 12, No. 6, pages 357-360 "CHEMISTRY LETTER S" (1978), no. 1, pages 49-50 (58) Fields investigated (Int. Cl. 7 , DB name) C07C 62/06 B01J 23/44 B01J 27/10 C07C 51/367 C07B 61/00 300 CA (STN) REGISTRY (STN )

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 式(II)【化1】 (R1、R2はアルキル基、アラルキル基、アリール基、シ
クロアルキル基を示す)で表される化合物をルイス酸触
媒の存在下、シクロペンタジエンとディールス・アルダ
ー反応させ、次いで加水分解を行い、接触水素添加後、
酸化する工程からなる式(I) 【化2】 で表される光学活性(+)−2−ヒドロキシ−2−ノル
ボルナンカルボン酸の製造方法。
1. A formula (II) ## STR1 ## (Wherein R 1 and R 2 represent an alkyl group, an aralkyl group, an aryl group, and a cycloalkyl group ) in a Diels-Alder reaction with cyclopentadiene in the presence of a Lewis acid catalyst, followed by hydrolysis, After catalytic hydrogenation,
Expression comprises the step of (I) oxide ## STR2 ## A method for producing an optically active (+)-2-hydroxy-2-norbornanecarboxylic acid represented by the formula:
【請求項2】 式(II')【化3】 (R1、R2はアルキル基、アラルキル基、アリール基、シ
クロアルキル基を示す 表される化合物をルイス酸触
媒の存在下、シクロペンタジエンとディールス・アルダ
ー反応させ、次いで加水分解を行い、接触水素添加後、
酸化する工程からなる式(I') 【化4】 で表される光学活性(−)−2−ヒドロキシ−2−ノル
ボルナンカルボン酸の製造方法。
Wherein formula (II ') embedded image (Wherein R 1 and R 2 represent an alkyl group, an aralkyl group, an aryl group, and a cycloalkyl group ) in a Diels-Alder reaction with cyclopentadiene in the presence of a Lewis acid catalyst, followed by hydrolysis, After catalytic hydrogenation,
Expression comprising the step of oxidizing (I ') embedded image A method for producing an optically active (-)-2-hydroxy-2-norbornanecarboxylic acid represented by the formula:
JP04056600A 1991-08-20 1992-02-10 Method for producing optically active 2-hydroxy-2-norbornanecarboxylic acid Expired - Fee Related JP3118939B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP04056600A JP3118939B2 (en) 1992-02-10 1992-02-10 Method for producing optically active 2-hydroxy-2-norbornanecarboxylic acid
US07/931,993 US5266728A (en) 1991-08-20 1992-08-19 Method for producing optically active 3-substituted-2-norbornanones and their intermediates
EP92307629A EP0528694B1 (en) 1991-08-20 1992-08-20 Method for producing optically active 3-substituted-2-norbornanones and their intermediates
SG1996001566A SG54127A1 (en) 1991-08-20 1992-08-20 Method for producing optically active 3-substituted-2-norbornanones and their immediates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP04056600A JP3118939B2 (en) 1992-02-10 1992-02-10 Method for producing optically active 2-hydroxy-2-norbornanecarboxylic acid

Publications (2)

Publication Number Publication Date
JPH05221918A JPH05221918A (en) 1993-08-31
JP3118939B2 true JP3118939B2 (en) 2000-12-18

Family

ID=13031714

Family Applications (1)

Application Number Title Priority Date Filing Date
JP04056600A Expired - Fee Related JP3118939B2 (en) 1991-08-20 1992-02-10 Method for producing optically active 2-hydroxy-2-norbornanecarboxylic acid

Country Status (1)

Country Link
JP (1) JP3118939B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003040812A (en) * 2001-07-27 2003-02-13 Kao Corp Method for producing cyclopentene
CN1308305C (en) * 2005-04-21 2007-04-04 浙江工业大学 Method for synthesizing imide base substituted endo compound

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"CHEMISTRY LETTERS"(1978),No.1,pages 49−50
"Org.Prep.Proced.Int."(1980),Vol.12,No.6,pages 357−360
"Tetrahedron Lett."(1981),Vol.22,No.34,pages 3231−3234
"Tetrahedron Lett."(1985),Vol.26,No.7,pages 811−814

Also Published As

Publication number Publication date
JPH05221918A (en) 1993-08-31

Similar Documents

Publication Publication Date Title
JP3119663B2 (en) Process for preparing compounds containing β-hydroxy-δ-lactone groups, analogs of (+)-compactin and (+)-mevinolin
US7323576B2 (en) Synthetic route to dronabinol
JPH05331128A (en) @(3754/24)r)-@(3754/24)-)-4-cyano-3-hydroxylactic acid t-butyl ester and its production
US5955627A (en) Process for the preparation of cyclopropylacetylene derivatives
JP3118939B2 (en) Method for producing optically active 2-hydroxy-2-norbornanecarboxylic acid
JP3123137B2 (en) Method for producing optically active 3-substituted-2-norbornanone
Sarmah et al. Nitro alkanes in organic synthesis: An efficient stereoselective synthesis of (+)-trans whisky lactone and (+)-eldanolide from nitro alkane synthons and using bakers' yeast reduction as the key step
JPH069483A (en) Production of substituted indanones
US4076732A (en) Derivatives of α-(6-carboxyhexyl) furfuryl alcohol
Seto et al. Preparation of (±)-2-(2, 3-2H2) jasmonic acid and its methyl ester, methyl (±)-2-(2, 3-2H2) jasmonate
JP4087329B2 (en) Muscon manufacturing method
JPH10212283A (en) Production of beta-hydroxy-gamma-butyrolactones and beta-(meth)acryoyloxy-gamma-butyrolactones
Takahashi et al. Total Synthesis of (+)-Methyl Phaseates
EP0528694B1 (en) Method for producing optically active 3-substituted-2-norbornanones and their intermediates
JP2511335B2 (en) Production method of 2,2-dimethyl-5- (2,5-dimethylphenoxy) pentanoic acid, production intermediate thereof, and production intermediate
JP3099317B2 (en) Method for producing (±) -nor umbrenolide
Bell et al. Synthesis of lignarenone B
JP4081619B2 (en) Method for producing optically active 5-hydroxy-2-decenoic acid and method for producing optically active soya lactone
EP1449838A1 (en) Process for the preparation of 2-coumaranone and substituted 2-coumaranones
JP2621309B2 (en) Asymmetric synthesis of diterpenes
JP3029753B2 (en) Method for producing meso- (3E, 7E) -5,6-bis (hydroxymethyl) -3,7-decadiene
JP3254746B2 (en) Terminal acetylene compound and method for producing the same
JPH0625089A (en) 3-isopropenylpentanoic acid derivative
JP2542843B2 (en) Novel norbornane derivative and method for producing the same
JP3028874B2 (en) Optical resolution method of (±) -2,5,5,8a-tetramethyl-1- (carboxymethyl) -2-hydroxydecalin

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20071013

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081013

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091013

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101013

Year of fee payment: 10

LAPS Cancellation because of no payment of annual fees